Recent publications

Petro, E., Martopullo, T., Mantel-Teeuwisse, A. K., van den Ham, H. A., & Suleman, F. (2025). 'Challenges in pediatric medicine access in Albania: insights from community Pharmacists'. Journal of Pharmaceutical Policy and Practice, 18(1), Article 2521425. https://doi.org/10.1080/20523211.2025.2521425

Lambert, M., van Dijk, L., Benko, R., Llor, C., Lykkegaard, J., Mantel-Teeuwisse, A. K., Pont, L., & Taxis, K. (2025). The role of the community pharmacist in antibiotic use – a commentary on current status and future perspectives. Exploratory Research in Clinical and Social Pharmacy, 20, Article 100652. https://doi.org/10.1016/j.rcsop.2025.100652

Petro, E., Joosse, I. R., Siebers, A. C. M., Martopullo, T., Hart, R. P. M., Mantel-Teeuwisse, A. K., van den Ham, H. A., & Suleman, F. (2025). Time and cost involved in measuring access to medicines: the case of Albania. BMC Research Notes, 18(1), Article 104. https://doi.org/10.1186/s13104-025-07168-5

van Vliet, E. D., Buhl, C., Jacobsen, R., Andersen, A., Almarsdóttir, A. B., Dermiki-Gkana, F., Oikonomou, C., Deligianni, E., Kontogiorgis, C., Kos, M., Čebron Lipovec, N., Ribeiro-Vaz, I., Silva, A. M., Ferreira, P., Poplavska, E., Abtahi, S., Hegger, I., & Leonardo Alves, T. (2025). Perspectives on the impact of regulatory measures on national COVID-19 vaccination programs: a qualitative study from six EU member states. Journal of Pharmaceutical Policy and Practice, 18(1), Article 2576620. https://doi.org/10.1080/20523211.2025.2576620

Zuidgeest, M. G. P., Heath, M., Lagerwaard, B., van Weelij, D. R., Rutgrink, L., Hanke, S., Vedenkannas, T., Kosonen, T., Collamati, S., Fons-Martinez, J., Veen, D., Gardarsdottir, H., Mackenzie, I. S., Dupont, S., Grobbee, D. E., & consortium, T. (2025). Bringing Trial Activities to Participants-The Trials@Home RADIAL Proof-of-Concept Trial Investigating Decentralization of Trials. Clinical Pharmacology & Therapeutics, 118(5), 1037-1045. https://doi.org/10.1002/cpt.70025

Morales, D. R., & Gardarsdottir, H. (2025). From Evidence to Impact: Closing the Loop in Pharmacovigilance With Real-World Data. Pharmacoepidemiology and Drug Safety, 34(11), Article e70244. https://doi.org/10.1002/pds.70244

Castillo-Cano, B., Riefolo, F., Villalobos, F., Martín-Pérez, M., Messina, D., Elbers, R., Brink-Kwakkel, D., Bissacco, C. A., Segundo, E., Saiz, L. C., Leache, L., Barbieri, E., Vaz, T., Gini, R., Klungel, O., & Martín-Merino, E. (2025). Impact and Effectiveness of COVID-19 mRNA Vaccination Against COVID-19 Hospitalisation in Paediatrics: A Cohort Study Using Two Linked Data Sources in Spain. Pharmacoepidemiology and Drug Safety, 34(11), Article e70239. https://doi.org/10.1002/pds.70239

Ljungdahl, N., Kempen, T., & Sporrong, S. K. (2025). Person-centred care in practice: Observational study of pharmacist and healthcare team encounters with patients with chronic pain in primary care. Research in Social and Administrative Pharmacy, 21(11). https://doi.org/10.1016/j.sapharm.2025.06.077

Kalkhoran, H. A., Verschueren, M. V., Peters, B. J. M., van de Garde, E. M. W., Smit, E. F., Bohringer, S., Cohen, D., Gulikers, J. L., Codrington, H., Guchelaar, H.-J., Visser, L. E., & Zwaveling, J. (2025). Real World Effectiveness of Durvalumab in Stage III Unresectable Non-small Cell Lung Cancer: What is the Role of PD-L1 Expression? Clinical Lung Cancer, 26(7), e599-e608.e2. https://doi.org/10.1016/j.cllc.2025.07.009

IMI Trials@Home Consortium, Gardarsdottir, H., Traore, H., Huntley, K., Mistry, D., de Jong, A. J., Legathe, A., de Smedt, T., Askin, S., Heath, M., Corriol-Rohou, S., Lagerwaard, B., & Zuidgeest, M. G. P. (2025). Regulatory Interactions and Learnings-RADIAL the Trials@Home Proof-of-Concept Trial on Decentralization. Clinical Pharmacology and Therapeutics, 118(5), 1046-1056. https://doi.org/10.1002/cpt.70078

Callenbach, M. H. E., van den Berg, S., Hulsbosch, A., Hollak, C. E. M., Leopold, C., Mantel-Teeuwisse, A. K., & Goettsch, W. G. (2025). Drivers of managed entry agreements to reduce reimbursement challenges of orphan medicinal products: the development of a matrix. Orphanet Journal of Rare Diseases, 20(1), Article 540. https://doi.org/10.1186/s13023-025-04020-8

Zafiropoulos, N., Pignatti, F., Kouroumalis, A., Guizzaro, L., Karres, D., Demolis, P., Tenhunen, O., Janssens, R., Taams, A., Bloem, L. T., Koenig, F., & Posch, M. (2025). A model structure for describing uncertainties in benefit-risk assessment of oncology drug applications. Frontiers in Medicine, 12, Article 1589578. https://doi.org/10.3389/fmed.2025.1589578

Yepes-Calderón, M., Nelissen, R. G. H. H., Bouvy, M. L., Rosendaal, F. L., Van Steenbergen, L. N., Dahan, A., & Gademan, M. G. J. (2025). 10-year trends in benzodiazepine, opioid, and concurrent use in hip and knee arthroplasty: a nationwide cohort study from the Netherlands. Acta Orthopaedica, 96, 771-779. https://doi.org/10.2340/17453674.2025.44755

on behalf of the COSEB Consortium, Korte, E. W. H., van den Akker, P. C., Kiritsi, D., Kottner, J., Pasmooij, A. M. G., Prinsen, C. A. C., Wally, V., Welponer, T., Spuls, P. I., Laimer, M., & Bolling, M. C. (2025). Core outcome domain sets for clinical trials in epidermolysis bullosa — a COSEB protocol to achieve consensus on “what” to measure. Trials, 26(1), Article 399. https://doi.org/10.1186/s13063-025-09052-w

Lasys, T., Santa-Ana-Tellez, Y., Siiskonen, S. J., Weir, D. L., Groenwold, R. H. H., & Gardarsdottir, H. (2025). Impact of diclofenac risk minimization measures addressing cardiovascular risk on analgesic use in musculoskeletal disorders. British Journal of Clinical Pharmacology, 91(10), 2998-3008. https://doi.org/10.1002/bcp.70142

Eskola, S. M., Sykes, N., Atzor, S., Garcia-Palacios, G., Dzambazoska, J., Spooner, Á., Rex, M., Neil, B., Chlebus, M., De Bruin, M. L., Gardarsdottir, H., & Neez, E. (2025). Innovative industry perspective: Assessing the proposed regulatory changes and their impact on innovation and competitiveness of the EU regulatory framework as part of the EU General Pharmaceutical Legislation revision. Drug Discovery Today, 30(10), Article 104468. https://doi.org/10.1016/j.drudis.2025.104468

Sadreghaemy, M., Philbert, D., Heerdink, E. R., Bouvy, M. L., Egberts, T. C. G., & Bloem, L. T. (2025). Patient preferences and attitudes regarding the environmental impact of medicines: A discrete choice experiment. British Journal of Clinical Pharmacology, 91(10), 2771-2781. https://doi.org/10.1002/bcp.70244

Ubiquitous Pharmacogenomics Consortium, Guchelaar, H.-J., van der Wouden, C. H., Manson, L. E. N., Abdullah-Koolmees, H., Blagec, K., Blagus, T., Böhringer, S., Cecchin, E., Cheung, K.-C., Deneer, V. H. M., Jonsson, S., Joefield-Roka, C., Just, K. S., Karlsson, M. O., Konta, L., Koopmann, R., Kriek, M., Lehr, T., ... Swen, J. J. (2025). Pharmacogenetic Implementation Studies-Lessons Learned From the PREPARE Study. Clinical Pharmacology and Therapeutics, 118(4), 803-812. https://doi.org/10.1002/cpt.3749

Werkman, N. C. C., Nielen, J. T. H., Tapia-Galisteo, J., Somolinos-Simón, F. J., Hernando, M. E., Wang, J., Jiu, L., Goettsch, W. G., Bosma, H., Schram, M. T., van Greevenbroek, M. M. J., Wesselius, A., Stehouwer, C. D. A., Driessen, J. H. M., & Garcia-Sáez, G. (2025). Prediction of glycaemic control and quality of life in people with type 2 diabetes using glucose-lowering drugs with machine learning-The Maastricht study. Diabetes, Obesity & Metabolism, 27(10), 5524-5537. https://doi.org/10.1111/dom.16598

Bruin, M. A. C., Lucas, L., Beijnen, J. H., Huitema, A. D. R., & Rosing, H. (2025). Stabilization of Abiraterone in Human Plasma Using the Esterase Inhibitor Bis(4-nitrophenyl) Phosphate: A Short Communication. Therapeutic Drug Monitoring, 47(5), 686-690. https://doi.org/10.1097/FTD.0000000000001339

Juhasova, Z., Karapinar-Carkit, F., & Weir, D. L. (2025). The use of international classification of diseases codes to identify hospital admissions linked with adverse drug events: Validation study. British Journal of Clinical Pharmacology, 91(10), 2910-2918. https://doi.org/10.1002/bcp.70116

Ljungdahl, N., Kälvemark-Sporrong, S., Tranberg, A., & Kempen, T. (2025). Pharmacists’ views on potential non-medical prescribing for pharmacists in Sweden: a nationwide survey study. International Journal of Clinical Pharmacy. Advance online publication. https://doi.org/10.1007/s11096-025-02006-x

Coppes, T., Philbert, D., van Gelder, T., Bouvy, M. L., & Koster, E. S. (2025). Barriers and facilitators for effective sick day guidance implementation. Journal of Nephrology. Advance online publication. https://doi.org/10.1007/s40620-025-02396-1

van Rijssel, T. I., van Thiel, G. J. M. W., Gardarsdottir, H., & van Delden, J. J. M. (2025). Which Benefits Can Justify Risks in Research? Response to Open Peer Commentaries. American Journal of Bioethics. Advance online publication. https://doi.org/10.1080/15265161.2025.2554767

Putnina, Z., Ernst, J. D., van der Tuin, I., Dirks, S., & Pieters, T. (2025). Evaluating the ArtBot Guide: A Toolkit for Enhancing Engagement with Digitized Museum Collections. Digital Society, 4, Article 66. https://doi.org/10.1007/s44206-025-00222-6

Ambrosio, L., Kamerling, C., de Jong, C. D. C., Herder, J. G. J. M., Egberts, T. A. C. G., & Deneer, V. V. H. M. (2025). Associatie tussen genetische varianten an oesofagitis bij NSCLC-patiënten behandeld met platinahoudend chemotherapie en radiotherapie: een prospectieve observationele studie. Pharmaceutisch Weekblad, 160(38), 19-24. https://www.knmp.nl/resolveuid/dac4022ca9e645a4ac285f4ed3f97d01

Kashmour, S., Kempen, T., Boussaboun, Y., Bouvy, M., & Gemmeke, M. (2025). Blaasontstekingszorg in apotheek: Vrouwen stellen voorwaarden. Pharmaceutisch Weekblad, 160(36), 18-20.

Costa, E., van den Ham, H. A., & Leufkens, H. G. M. (2025). Challenges and opportunities of adding CFTR modulators for cystic fibrosis to the WHO essential medicines list. Journal of Cystic Fibrosis, 24(5), 920-922. https://doi.org/10.1016/j.jcf.2025.06.006

Mahomedradja, R. F., Bognàr, T., van Schie, K. E., Kuipers, I. T., de Witte, M. A., Kuball, J. H. E., Nur, E., Wilhelm, B. J., Heerma van Voss, M. R., Franken, L., Lalmohamed, A., Swart, E. N. L., de Leeuw, D. C., & Bartelink, I. H. (2025). Model-Informed Precision Dosing of Busulfan for Children and Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Critical Evaluation of Current PK Models and Dose Recommendations. Clinical Pharmacology and Therapeutics, 118(3), 723-734. https://doi.org/10.1002/cpt.3748

Willemsen, A., Rutten-van Mölken, M., Al Dulaimi, R., Schelleman, H., Goettsch, W., & Timmers, L. (2025). Preparing for the EU HTA Regulation: Insights from the Dutch Perspective. Journal of market access & health policy, 13(3), 1-19. Article 35. https://doi.org/10.3390/jmahp13030035

Essink, S. C. M., Zomerdijk, I. M., Straus, S. M. J. M., Gardarsdottir, H., & De Bruin, M. L. (2025). Risk Minimisation Measures of Advanced Therapy Medicinal Products Authorised in the EU Between 2009 and 2023: A Cross-Sectional Study. Drug Safety, 48(9), 1005-1022. https://doi.org/10.1007/s40264-025-01550-9

van Geloven, N., Keogh, R. H., van Amsterdam, W., Cinà, G., Krijthe, J. H., Peek, N., Luijken, K., Magliacane, S., Morzywołek, P., van Ommen, T., Putter, H., Sperrin, M., Wang, J., Weir, D. L., & Didelez, V. (2025). The Risks of Risk Assessment: Causal Blind Spots When Using Prediction Models for Treatment Decisions. Annals of Internal Medicine, 178(9), 1326-1333. https://doi.org/10.7326/ANNALS-24-00279

Coppes, T., Prins, H., van Amerongen, K. A., van Gelder, T., Koster, E. S., & Bouvy, M. L. (2025). Using simulated patient methodology to assess sick day guidance in community pharmacy: The case of an elderly patient with diabetes. Exploratory Research in Clinical and Social Pharmacy, 19, Article 100623. https://doi.org/10.1016/j.rcsop.2025.100623

Eroglu, T. E., Coronel, R., & Souverein, P. C. (2025). Sodium-glucose cotransporter-2 inhibitors and the risk of all-cause mortality: a population-based cohort study using the UK Clinical Practice Research Datalink. Open Heart, 12(2), Article e003254. https://doi.org/10.1136/openhrt-2025-003254

Verschueren, M. V., Verschueren, D. V., van de Garde, E. M. W., & Bloem, L. T. (2025). A Bayesian Approach to Compare Accumulating Survival Data From Clinical Practice With RCT Data: A Case Study in Non-Small Cell Lung Cancer Patients. CPT: Pharmacometrics and Systems Pharmacology. Advance online publication. https://doi.org/10.1002/psp4.70075

Su, L., Chen, L., Betigeri, S., Dreyer, N., Gardarsdottir, H., Hendricks-Sturrup, R., & Burcu, M. (2025). Clinical Trials With Pragmatic Elements: A Review of Use Cases and Real-World Data Utilization. Clinical Pharmacology and Therapeutics. Advance online publication. https://doi.org/10.1002/cpt.70033

Jansen, M., Gemmeke, M., Bouvy, M., & Kempen, T. (2025). Nog aarzeling bij blaasontstekingservice vanuit de apotheek: Relatieve voordeel van taakverschuiving naar apotheek onvoldoende duidelijk . Pharmaceutisch Weekblad, 160(33-34). https://www.pw.nl/achtergrond/2025/nog-aarzeling-bij-blaasontstekingservice-vanuit-de-apotheek

Schouten, W. M., Van Bocxlaer, K., Rosing, H., Huitema, A. D. R., Beijnen, J. H., Kratz, J. M., Mowbray, C. E., & Dorlo, T. P. C. (2025). Quantitative analysis of DNDI-6174 using UPLC-MS/MS: A preclinical target site pharmacokinetic study. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 1262, Article 124652. https://doi.org/10.1016/j.jchromb.2025.124652

Jacobs, T. G., Ooms, G. I., Mantel-Teeuwisse, A. K., & Suleman, F. (2025). Commentary: Pediatric HIV Treatment: Nurturing Access Through Health Facility Availability and Stock-out Monitoring. Pediatric Infectious Disease Journal, 44(8), 785-786. https://doi.org/10.1097/INF.0000000000004814

de Jong, A. J., Gardarsdottir, H., Santa-Ana-Tellez, Y., de Boer, A., & Zuidgeest, M. G. (2025). Experiences with low-intervention clinical trials-the new category under the European Union Clinical Trials Regulation. Clinical Trials, 22(4), 494-500. https://doi.org/10.1177/17407745241309293

Chen, M., Kuzyakov, Y., Zhou, J., Zamanian, K., Wang, S., Abdalla, K., Wang, J., Li, X., Li, H., Zhang, H., Mganga, K. Z., Li, Y., & Blagodatskaya, E. (2025). High soil salinity reduces straw decomposition but primes soil organic carbon loss. Soil Biology and Biochemistry, 207, 1-11. Article 109835. https://doi.org/10.1016/j.soilbio.2025.109835

Egberts, T., van Puijenbroek, E., & Leufkens, B. (2025). Obituary Ronald Meyboom: A Professional Life Devoted to Pharmacovigilance. Drug Safety, 48(8), 953-954. https://doi.org/10.1007/s40264-025-01577-y

Bartelink, I. H., Lalmohamed, A., Bognar, T., Nur, E., & Boelens, J. J. (2025). Optimizing Allogeneic Hematopoietic Cell Transplantation Outcomes Through Busulfan PK/PD. Transplantation and Cellular Therapy, 31(8), 477-479. https://doi.org/10.1016/j.jtct.2025.07.008

Rijmers, J., Lebre, M. C., Beijnen, J. H., & Schinkel, A. H. (2025). Resistance mutations and the blood-brain barrier: Key challenges in targeted treatment of brain metastatic non-small cell lung cancer. Acta Pharmaceutica Sinica B, 15(8), 3833-3851. https://doi.org/10.1016/j.apsb.2025.06.002

Narsai, K., Leufkens, H. G. M., Brinkhuis, F., Mantel-Teeuwisse, A. K., & van den Ham, H. A. (2025). Transitioning to regulatory harmonisation for medicines: a comparison between Africa and Europe. Drug Discovery Today, 30(8), Article 104416. https://doi.org/10.1016/j.drudis.2025.104416

Schouten, WM., van Bocxlaer, K., Rosing, H., Huitema, AD. R., Beijnen, JH., Kratz, JM., Mowbray, CE., & Dorlo, TP. C. (2025). Validated LC-MS/MS Method for Quantifying the Antiparasitic Nitroimidazole DNDI-0690 in Preclinical Target Site PK/PD Studies. Biomedical Chromatography, 39(8), 1-13. Article e70158. https://doi.org/10.1002/bmc.70158

Vallejo-Yagüe, E., de Vries, S. T., La Parra-Casado, D., Gardarsdottir, H., Faquetti, M. L., van Valkengoed, I., Aubrun, E., Douros, A., Guedes, S., Martinez-De La Torre, A., Wested, J., Ochi, T., Schumacher Dimech, A. M., Clair, C., Mehta, I., Ida, F., Soriano Gabarró, M., Korzh, O., Martínez-González, M., ... Nordeng, H. (2025). Advancing Health Equity in Europe: Explore, Tailor, Implement, and Evaluate (ETIE)-A Framework of Diversity and Fairness in Pharmacoepidemiologic Research. Pharmacoepidemiology and Drug Safety, 34(7), Article e70175. https://doi.org/10.1002/pds.70175

Barbier, L., Moscariello, P., Leufkens, H. G., Herold, R., & Pasmooij, A. M. G. (2025). A new European platform for advancing regulatory science research. Nature Reviews Drug Discovery, 24(7), 485-486. https://doi.org/10.1038/d41573-025-00024-y

Hogervorst, M. A., Vreman, R. A., Oduol, T. A., Mantel-Teeuwisse, A. K., Goettsch, W. G., & Kesselheim, A. S. (2025). Evolving Recommendations for Patient Populations Among Oncology Medicines: A Quantitative and Qualitative Analysis. Clinical Pharmacology and Therapeutics, 118(1), 95-105. https://doi.org/10.1002/cpt.3628

Maisonneuve, E., De Bruin, O., Favre, G., Oakley, E., Kim, J. Y. H., Farooq, F., Al-Fadel, N., Almutairi, A., Del Mar Gil, M., Fernandez Buhigas, I., Visentin, S., Cosmi, E., Surita, F., Souza, R. T., Cecatti, J. G., Costa, M. L., Sanin-Blair, J., Tolosa, J. E., Hadar, E., ... Sturkenboom, M. C. J. M. (2025). How COVID-19 Treatment in Pregnancy Reflects Healthcare Utilization During a Pandemic: A Two-Stage Individual Participant Data Meta-Analysis Combining Case-Based Registries. Pharmacoepidemiology and Drug Safety, 34(7), Article e70180. https://doi.org/10.1002/pds.70180

Lambert, M., Mmassy, J., Kabissi, S., Benizeth, C., Baltazary, G., Maganda, B. A., & Taxis, K. (2025). Lessons from the field: implementing pharmacy services in the Tanzanian hospital setting. International Health. Advance online publication. https://doi.org/10.1093/inthealth/ihaf079

Engelen, E. M. C., Knol, W., Wuyts, S. C. M., Theunissen, D. A., Vondeling, A. M., Cooijmans, S., van Herwaarden, N., Kramers, C., van den Bemt, P. M. L. A., van Agtmael, M. A., & Bouvy, M. L. (2025). Older patients' experiences and needs regarding pharmacotherapeutic care in-hospital and after discharge. Patient Education and Counseling, 136, Article 108754. https://doi.org/10.1016/j.pec.2025.108754

van Rijt-Weetink, Y. R. J., van Gendt, J., Egberts, T. C. G., van Hunsel, F. P. A. M., Lewis, D. J., Yates, L. M., Winterfeld, U., & van Puijenbroek, E. P. (2025). Quality of Clinical Information in Pregnancy Pharmacovigilance Data Sources-A Contribution of the ConcePTION Project. Pharmacoepidemiology and Drug Safety, 34(7), Article e70182. https://doi.org/10.1002/pds.70182

Meije, R. I., Selvanayagam, T., Philbert, D., Bouvy, M. L., Haeck, I. M., Dreesens, D., van Tuyll-van Serooskerken, A.-M., & Gemmeke, M. (2025). New educational materials about atopic dermatitis for primary care: pharmacy staff's and patients' perspectives. Journal of Public Health . Advance online publication. https://doi.org/10.1007/s10389-025-02535-9

Knikman, J. E., de With, M., Heersche, N., Lopez-Yurda, M., Baars, A., Creemers, G. J., Droogendijk, H. J., Fiets, E., Imholz, A. L. T., Iersel, L. V. V., Mandigers, C. M. P. W., van de Vendel, A. J., Jeurissen, F. J. F., Nieboer, P., Deenen, M. J., van de Poel, M. H. W., Wymenga, M. N. M., van Schaik, R. H. N., van den Bosch, B. J. C., ... Cats, A. (2025). Dose-individualisation of fluoropyrimidines based on pre-treatment serum uracil levels: the Alpe2U study. European Journal of Cancer, 224, Article 115483. https://doi.org/10.1016/j.ejca.2025.115483

Kanning, J. P., Abtahi, S., Klungel, O. H., & Ruigrok, Y. M. (2025). Author Response: Prescribed Drug Use and Aneurysmal Subarachnoid Hemorrhage Incidence: A Drug-Wide Association Study. Neurology, 104(12), Article e210035. https://doi.org/10.1212/WNL.0000000000210035

Hellamand, M., Moleman, T. E., Post, A. P., Mantel-Teeuwisse, A. K., Suleman, F., & Van Den Ham, H. A. (2025). Time to inclusion of selected medicines for priority diseases in National Essential Medicines Lists compared with the WHO Model List. BMJ Global Health, 10(6), Article e018550. https://doi.org/10.1136/bmjgh-2024-018550

Opalska, A., Kwa, M., & Leufkens, H. (2025). Implementation of indication restrictions made by European regulatory action for antibiotics - amoxicillin. European Journal of Pharmaceutical Sciences, 209, Article 107106. https://doi.org/10.1016/j.ejps.2025.107106

Miguel, J. W. A. M., van Veen, N. L., Jacobs, W., Damhuis, R. A. M., van Uden-Kraan, C. F., & van de Garde, E. M. W. (2025). Applied first-line systemic treatments, treatment modifications and outcomes in non-oncogenic metastatic non-small cell lung cancer in the Netherlands in 2019–2020: A nationwide study. Cancer Epidemiology, 96, Article 102809. https://doi.org/10.1016/j.canep.2025.102809

Verschueren, M. V., Hiensch, D. T. A., Plomp, P. M. J., Kastelijn, L. A., van de Garde, E. M. W., & Peters, B. J. M. (2025). Comparative Effectiveness of Nivolumab and Ipilimumab Plus Chemotherapy Versus Pembrolizumab Plus Chemotherapy in PD-L1 Negative Metastatic Non-Small Cell Lung Cancer Patients. Clinical Lung Cancer, 26(4), e243-e248.e1. https://doi.org/10.1016/j.cllc.2025.01.009

Lentzas, A., Their, A., Beijnen, J. H., de Gooijer, M. C., & van Tellingen, O. (2025). Development and Validation of a Rapid and Simple LC-MS/MS Method for Quantification of the Anti-Microtubule, Anti-Cancer Agent ABT-751 in Human and Mouse Plasma and Mouse Tissues. Biomedical Chromatography, 39(6), 1-13. Article e70099. https://doi.org/10.1002/bmc.70099

Kruijtbosch, M., Floor-Schreudering, A., van Leeuwen, E., & Bouvy, M. L. (2025). Fostering moral reflectivity in community pharmacists through moral case deliberation using the dilemma method. International Journal of Clinical Pharmacy, 47(3), 676-687. https://doi.org/10.1007/s11096-024-01854-3

Jadoenathmisier, K. D., Gardarsdottir, H., Mol, P. G. M., & Pasmooij, A. M. G. (2025). Insights from the European Medicines Agency on digital health technology derived endpoints. Drug Discovery Today, 30(6), Article 104388. https://doi.org/10.1016/j.drudis.2025.104388

Jansen-Groot Koerkamp, E. A. W., Simsek, I., Badawy, E., Heringa, M., & Bouvy, M. L. (2025). Patient counselling on opioids by pharmacy technicians: A mixed-method study to explore facilitators and barriers. PEC Innovation, 6, Article 100382. https://doi.org/10.1016/j.pecinn.2025.100382

Voogd, D. W. M., Lucassen, M. J. J., van der Noll, R., Zielhuis, S. W. J., Boss, D., Beijnen, J. H., Rosing, H., Tibben, M., Huitema, A. D. R., Schellens, J. H. M., & Steeghs, N. (2025). Phase I Study of Sorafenib Combined with Gemcitabine and Carboplatin in Patients with Advanced Solid Tumors. Oncology and Therapy, 13(2), 465-483. Article e82209. https://doi.org/10.1007/s40487-025-00340-8

Pan, X., Feng, B., Chen, Y., Wang, J., Pan, X., Lam, T., & Pan, J. (2025). Prognostic models for lung cancer in smokers and nonsmokers: an updated systematic review and meta-analysis. Oncology and Translational Medicine, 11(3), 112-117. https://doi.org/10.1097/ot9.0000000000000091

Reesink, D. J., Voskuilen, C. S., van de Garde, E. M. W., Hendricksen, K., Horenblas, S., van Melick, H. H. E., & van Rhijn, B. W. G. (2025). Survival in Responders and Nonresponders of Neoadjuvant and Induction Chemotherapy in Invasive Urothelial Carcinoma of the Urinary Bladder: A Clinical and Pathological Stage-Matched Analysis. Clinical Genitourinary Cancer, 23(3), Article 102319. https://doi.org/10.1016/j.clgc.2025.102319

Leung, M. W. Y., Garde, E. M. W. V. D., Uitdehaag, B. M. J., Klungel, O. H., & Bazelier, M. T. (2025). The relative risk of infection in people with multiple sclerosis using disease-modifying treatment: a systematic review of observational studies. Neurological Sciences, 46(6), 2555-2569. https://doi.org/10.1007/s10072-025-08018-9

Davies, L. E. M. (2025). Pain Points: Patient Perspectives on Opioid Treatment for Chronic Pain. [Doctoral thesis 1 (Research UU / Graduation UU), Universiteit Utrecht]. Utrecht University. https://doi.org/10.33540/2868

Cam, H., Franzon, K., Östman, V., Kälvemark Sporrong, S., Kempen, T. G. H., Nielsen, E. I., Lindner, K.-J., Ekelo, B., Bernsten, C., Ehlin, U., Lindmark, S., Hadziosmanovic, N., & Gillespie, U. (2025). Improved Medication communication and Patient involvement At Care Transitions (IMPACT-care): study protocol for a pre-post intervention trial in older hospitalised patients. BMJ Open, 15(5), Article e099547. https://doi.org/10.1136/bmjopen-2025-099547

Meertens, M., Rosing, H., Steeghs, N., Beijnen, J. H., & Huitema, A. D. R. (2025). Advancing Therapeutic Drug Monitoring for Oral Targeted Anticancer Drugs: From Hospital-Based Towards Home-Sampling. Biomedical Chromatography, 39(5), Article e70056. https://doi.org/10.1002/bmc.70056

Jonker, A. H., Tataru, E. A., Dimmock, D. P., Bateman-House, A., Graessner, H., Baynam, G., Augustine, E. F., Jaffe, A., Pasmooij, A. M. G., Iliach, O., Horgan, R., Davies, J., Mitkus, S., Lapteva, L., Synofzik, M., Yu, T. W., O’Connor, D., & Aartsma-Rus, A. (2025). From roadmap to a sustainable end-to-end individualized therapy pathway. Therapeutic Advances in Rare Disease, 6. https://doi.org/10.1177/26330040251339204

de Haart, K., Asao, K., Ataher, Q., Geier, J., Hillen, J., Huang, K., Mol, P. G. M., Rivera, D., Wang, H., Yang, H., Zhan, S., Hoogendoorn, W. E., & Bloem, L. T. (2025). Long-term follow-up after authorization of gene therapy: leveraging real-world data. Drug Discovery Today, 30(5), Article 104337. https://doi.org/10.1016/j.drudis.2025.104337

Liang, D., Paul, A. K., Weir, D. L., Deneer, V. H. M., Greiner, R., Siebes, A., & Gardarsdottir, H. (2025). Methods in dynamic treatment regimens using observational healthcare data: A systematic review. Computer Methods and Programs in Biomedicine, 263, Article 108658. https://doi.org/10.1016/j.cmpb.2025.108658

Houwen, J. P. A., Lalmohamed, A., Zwaan, J., Egberts, T. C. G., Duyvendak, M., Fiolet, A. T. L., & Mosterd, A. (2025). The effect of colchicine on coagulation in patients with chronic coronary disease who use vitamin K antagonists. European Journal of Clinical Pharmacology, 81(5), 719-725. https://doi.org/10.1007/s00228-025-03815-9

Beex-Oosterhuis, M. M., Lau, S. F. C., van Kesteren, C., Verloop, S., Grootens, K. P., Faber, G., Van Gool, A. R., Heerdink, E. R. R., van Marum, R. J., & Touw, D. J. (2025). The Impact of Once Daily Dosing on Protein Binding of Clozapine and Norclozapine. Journal of Clinical Psychopharmacology, 45(3), 231-235. https://doi.org/10.1097/JCP.0000000000001979

Wang, X., Zhu, M. X., Wang, J. F., Liu, P., Zhang, L. Y., Zhou, Y., Lin, X. X., Du, Y. D., & He, K. L. (2025). Multivariable prognostic models for post-hepatectomy liver failure: An updated systematic review. World Journal of Hepatology, 17(4), Article 103330. https://doi.org/10.4254/wjh.v17.i4.103330

Overmars, L. M., van Es, B., Groepenhoff, F., De Groot, M. C. H., Somsen, G. A., Bots, S. H., Tulevski, I. I., Hofstra, L., den Ruijter, H. M., van Solinge, W. W., Hoefer, I., & Haitjema, S. (2025). Optimising coronary imaging decisions with machine learning: an external validation study. Open Heart, 12(1), Article e003072. https://doi.org/10.1136/openhrt-2024-003072

Leung, M. W. Y. (2025). Pharmacoepidemiologic studies of infection among people with multiple sclerosis: Occurrence and effects of pharmacotherapy. [Doctoral thesis 1 (Research UU / Graduation UU), Universiteit Utrecht]. Utrecht University. https://doi.org/10.33540/2837

Postma, D. J., De Smet, P. A. G. M., Mantel-Teeuwisse, A. K., Leufkens, H. G. M., & Notenboom, K. (2025). Upstream pharmaceutical supply chains of 10 high-use pharmaceuticals in the Netherlands: a cohort study. BMJ Open, 15(4), Article e099697. https://doi.org/10.1136/bmjopen-2025-099697

Westein, M. P. D. (2025). Training and Assessment in Workplace-based Community Pharmacy: Creating Foundations and Nurturing Progress. [Doctoral thesis 1 (Research UU / Graduation UU), Universiteit Utrecht]. Utrecht University. https://doi.org/10.33540/2807

MOLecular Evaluation of Melanocytic Ambiguous Tumours (MOLEMAT) Investigators, Ebbelaar, C. F., Jansen, A. M. L., Speet, L. C. M., Schutgens, F., Zoetemeyer, S., Cleton-Jansen, A.-M., van Dijk, M. R., Breimer, G. E., Bloem, L. T., de Leng, W. W. J., van Doorn, R., Suijkerbuijk, K. P. M., Schrader, A. M. R., & Blokx, W. A. M. (2025). Clinical outcomes and genomic profiles of MAP2K1-mutated primary cutaneous melanocytic tumours. EBioMedicine, 114, Article 105643. https://doi.org/10.1016/j.ebiom.2025.105643

Tataru, E. A., Dooms, M., Gonzaga-Jauregui, C., Pasmooij, A. M. G., O'Connor, D. J., & Jonker, A. H. (2025). Drug–device combinations in rare diseases: Challenges and opportunities. Drug Discovery Today, 30(4), Article 104343. https://doi.org/10.1016/j.drudis.2025.104343

Essink, S. C. M., Zomerdijk, I. M., Goedecke, T., Straus, S. M. J. M., Gardarsdottir, H., & De Bruin, M. L. (2025). Duration of Time Intervals for Risk Minimization Measure Effectiveness Studies. Clinical Pharmacology and Therapeutics, 117(4), 1106-1114. https://doi.org/10.1002/cpt.3569

Emond, S. K., Goettsch, W. G., & Ollendorf, D. A. (2025). Harmonizing HTA Evidence Needs and Expectations: Challenges and Opportunities to Improve Evidence Generation, Ensure Access and Affordability. Clinical Pharmacology and Therapeutics, 117(4), 938-945. https://doi.org/10.1002/cpt.3579

Krishna, R., Jonker, A. H., Morel, T., Sakushima, K., Pasmooij, A. M. G., & O'Connor, D. (2025). IRDiRC perspectives on the application of digital biomarkers in therapeutic development for rare diseases. Nature Reviews Drug Discovery, 24(4), 233-234. https://doi.org/10.1038/d41573-024-00196-z

Ensing, H. T., Kurt, N., Janssen, R. A., Koster, E. S., & Heerdink, E. R. (2025). Pharmacist-led new medicine service: a real-world cohort study in the Netherlands on drug-related problems, satisfaction, and self-efficacy in cardiovascular patients transitioning to primary care. International Journal of Clinical Pharmacy, 47(2), 325–334. https://doi.org/10.1007/s11096-024-01829-4

Saylor, D., Rijke, N., McDonell, J., Laurson-Doube, J., Avasarala, J., Baldin, E., Banerjee, T. K., Bogdanovic, I., Bove, R., Chawla, D. K., Costello, K., Del Giovane, C., Abkari, N. E., Filippini, G., Foschi, M., Gonzalez-Lorenzo, M., Helme, A., Jacobs, D., Kalincik, T., ... Piggott, T. (2025). Recommendations for essential medicines for multiple sclerosis in low-resource settings. Multiple Sclerosis Journal, 31(4), 454-473. https://doi.org/10.1177/13524585241308134

van Loon, E., Heringa, M., Floor-Schreudering, A., de Smet, P., & Bouvy, M. (2025). Relevance of therapeutic prescription modifications in Dutch community pharmacies. The International Journal of Pharmacy Practice, 33(2), 169-179. https://doi.org/10.1093/ijpp/riae060

Lu, Z., Dong, B., Cai, H., Tian, T., Wang, J., Fu, L., Wang, B., Zhang, W., Lin, S., Tuo, X., Wang, J., Yang, T., Huang, X., Zheng, Z., Xue, H., Xu, S., Liu, S., Sun, P., & Zou, H. (2025). Identifying Data-Driven Clinical Subgroups for Cervical Cancer Prevention With Machine Learning: Population-Based, External, and Diagnostic Validation Study. JMIR Public Health and Surveillance, 11, Article e67840. https://doi.org/10.2196/67840

Kanning, J. P., Wang, J., Abtahi, S., Geerlings, M. I., & Ruigrok, Y. M. (2025). Identifying novel risk factors for aneurysmal subarachnoid haemorrhage using machine learning. Scientific Reports, 15(1), Article 9256. https://doi.org/10.1038/s41598-025-88826-3

Costa, E., Del Grosso, V., Cappello, B., Genazzani, A. A., Huttner, B., Leufkens, H. G. M., Magrini, N., Nonino, F., Wirtz, V. J., van den Ham, H. A., & Moja, L. (2025). Medicines not recommended for inclusion in the who essential medicines list: a retrospective observational study. Frontiers in Medicine, 12, Article 1517020. https://doi.org/10.3389/fmed.2025.1517020

van der Heijden, L. T., Tibben, M. M., Ali, M. I. M., Aardenburg, L. G. J., Steeghs, N., Beijnen, J. H., Rosing, H., & Huitema, A. D. R. (2025). An ultra-sensitive liquid chromatography tandem mass spectrometry method for the simultaneous quantification of 2H6-alectinib and alectinib in human plasma to support a microtracer food-effect trial. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 1253, Article 124488. https://doi.org/10.1016/j.jchromb.2025.124488

Lievense, J. J., Nijenhuis, C., Jedema, I., Jonker-Hoogerkamp, A., Moyers, J. T., Hamid, O., Beijnen, J. H., Haanen, J. B. A. G., & Nuijen, B. (2025). Defining the Quality Attributes for Tumor-Infiltrating Lymphocyte Medicinal Products. Transplantation and Cellular Therapy, 31(3), S610-S625. https://doi.org/10.1016/j.jtct.2024.04.015

Verschueren, M. V., Tassopoulou, V. P., Visscher, R., Schuurkamp, J., Peters, B. J. M., Koopman, M., van de Garde, E. M. W., Egberts, A. C. G., & Bloem, L. T. (2025). Definitions, measurement, and reporting of progression-free survival in randomized clinical trials and observational studies of patients with advanced non-small-cell lung cancer treated with immunotherapy: a scoping review. ESMO Real World Data and Digital Oncology, 7, Article 100118. https://doi.org/10.1016/j.esmorw.2025.100118

Smit, J. M., Van Der Zee, P. A., Stoof, S. C. M., Van Genderen, M. E., Snijders, D., Boersma, W. G., Confalonieri, P., Salton, F., Confalonieri, M., Shih, M.-C., Meduri, G. U., Dequin, P.-F., Le Gouge, A., Lloyd, M., Karunajeewa, H., Bartminski, G., Fernández-Serrano, S., Suárez-Cuartín, G., van Klaveren, D., ... Endeman, H. (2025). Predicting benefit from adjuvant therapy with corticosteroids in community-acquired pneumonia: a data-driven analysis of randomised trials. The Lancet Respiratory Medicine, 13(3), 221-233. https://doi.org/10.1016/S2213-2600(24)00405-3

Lin, L., Lucassen, M. J. J., van der Noort, V., Egberts, T. C. G., Beijnen, J. H., & Huitema, A. D. R. (2025). The feasibility of using real world data as external control arms in oncology trials. Drug Discovery Today, 30(3), Article 104324. https://doi.org/10.1016/j.drudis.2025.104324

Callenbach, M. H. E. (2025). Fertile Grounds for Outcome-based Managed Entry Agreements? Potential suitability and desirability for highly priced novel therapies. [Doctoral thesis 1 (Research UU / Graduation UU), Universiteit Utrecht]. Utrecht University. https://doi.org/10.33540/2704

Dong, B., Lu, Z., Yang, T., Wang, J., Zhang, Y., Tuo, X., Wang, J., Lin, S., Cai, H., Cheng, H., Cao, X., Huang, X., Zheng, Z., Miao, C., Wang, Y., Xue, H., Xu, S., Liu, X., Zou, H., & Sun, P. (2025). Development, validation, and clinical application of a machine learning model for risk stratification and management of cervical cancer screening based on full-genotyping hrHPV test (SMART-HPV): a modelling study. The Lancet Regional Health - Western Pacific, 55, Article 101480. https://doi.org/10.1016/j.lanwpc.2025.101480

Lasys, T., Santa-Ana-Tellez, Y., Siiskonen, S. J., Groenwold, R. H. H., & Gardarsdottir, H. (2025). Impact of Pharmacovigilance Interventions Targeting Fluoroquinolones on Antibiotic Use in the Netherlands and the United Kingdom. Pharmacoepidemiology and Drug Safety, 34(2), Article e70081. https://doi.org/10.1002/pds.70081

Davies, L. E. M., van den Ham, H. A., Schellekens, A. F. A., Philbert, D., & Bouvy, M. L. (2025). Patient satisfaction with prescription opioid education in primary care. Patient Education and Counseling, 131, Article 108572. https://doi.org/10.1016/j.pec.2024.108572

Trials@Home Consortium, de Jong, A. J., Zuidgeest, M. G. P., Santa-Ana-Tellez, Y., Hallgreen, C. E., van Sloten, T. T., de Boer, A., & Gardarsdottir, H. (2025). The impact of operational trial approaches on representativeness: Comparison of decentralized clinical trial participants, conventional trial participants, and patients in daily practice. Drug Discovery Today, 30(2), Article 104304. https://doi.org/10.1016/j.drudis.2025.104304

Van Gelder, T. G., Vergoossen, D., Zonnenberg, I. A., Lalmohamed, A., Koole-Oostveen, M. I., van Reij, E. M. L., van Loon, A., & Egberts, T. C. G. (2025). Physical compatibility of insulin aspart, lidocaine, alprostadil and vancomycin with individualised two-in-one parenteral nutrition used in the neonatal intensive care unit. European Journal of Hospital Pharmacy, Article ejhpharm-2024-004300. Advance online publication. https://doi.org/10.1136/ejhpharm-2024-004300

Schultze, A., Martin, I., Messina, D., Bots, S., Belitser, S., Carreras-Martínez, J. J., Correcher-Martinez, E., Urchueguía-Fornes, A., Martín-Pérez, M., García-Poza, P., Villalobos, F., Pallejà-Millán, M., Bissacco, C. A., Segundo, E., Souverein, P., Riefolo, F., Durán, C. E., Gini, R., Sturkenboom, M., ... Douglas, I. (2025). Corrigendum to “A comparison of four self-controlled study designs in an analysis of COVID-19 vaccines and myocarditis using five European databases” [Vaccine 42 (12) (2024) 3039–3048, (S0264410X2400330X), (10.1016/j.vaccine.2024.03.043)]. Vaccine, 44, 126438. Article 126438. https://doi.org/10.1016/j.vaccine.2024.126438

Mertens, J. F., Hessel, M. H. M., Kempen, T. G. H., Böhringer, S., Norbart, A. F., Walinga, C. W., & van Gelder, T. (2025). Evaluation of an interprofessional education program involving medical and pharmacy students: a mixed-method study. BMC Medical Education, 25(1), Article 48. https://doi.org/10.1186/s12909-024-06574-w

van Baalen, M., van der Velden, L., van der Gronde, T., & Pieters, T. (2025). Developing a translational research framework for MDD: combining biomolecular mechanisms with a spiraling risk factor model. Frontiers in Psychiatry, 15, 1-21. Article 1463929. https://doi.org/10.3389/fpsyt.2024.1463929

Schouten, W. M., Van Bocxlaer, K., Rosing, H., Huitema, A. D. R., Beijnen, J. H., Kratz, J. M., Mowbray, C. E., & Dorlo, T. P. C. (2025). Development and validation of ultra-performance liquid chromatography tandem mass spectrometry methods for the quantitative analysis of the antiparasitic drug DNDI-6148 in human plasma and various mouse biomatrices. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 1250, 1-11. Article 124377. https://doi.org/10.1016/j.jchromb.2024.124377

Sindahl, P., Møllebæk, M., Gardarsdottir, H., De Bruin, M. L., Hallgreen, C. E., & Clemmensen, M. H. (2025). Implementation of electronic distribution of Direct Healthcare Professional Communications by the Danish Medicines Agency: a survey study of physicians’ experiences and preferences. Therapeutic Advances in Drug Safety, 16, Article 20420986251333911. https://doi.org/10.1177/20420986251333911

Hogervorst, M. A., Soman, K. V., Gardarsdottir, H., Goettsch, W. G., & Bloem, L. T. (2025). Analytical Methods for Comparing Uncontrolled Trials with External Controls from Real-World Data: a Systematic Literature Review and Comparison to European Regulatory and Health Technology Assessment Practice. Value in Health, 28(1), 161-174. https://doi.org/10.1016/j.jval.2024.08.002

Bots, S. H., Belitser, S., Groenwold, R. H. H., Durán, C. E., Riera-Arnau, J., Schultze, A., Messina, D., Segundo, E., Douglas, I., Carreras, J. J., Garcia-Poza, P., Gini, R., Huerta, C., Martín-Pérez, M., Martin, I., Paoletti, O., Bissacco, C. A., Correcher-Martínez, E., Souverein, P., ... Klungel, O. H. (2025). Applying two approaches to detect unmeasured confounding due to time-varying variables in a self-controlled risk interval design evaluating COVID-19 vaccine safety signals, using myocarditis as a case example. American Journal of Epidemiology, 194(1), Article kwae172. https://doi.org/10.1093/aje/kwae172

Hermans, A. M. M., Bakker, E., Starokozhko, V., den Otter, L., Elferink, A. J. A., Bradshaw, A., Guizzaro, L., Mol, P. G. M., & Pasmooij, A. M. G. (2025). Biomarkers for neurodegenerative diseases in regulatory decision-making by the European Medicines Agency. Alzheimer's and Dementia: Translational Research and Clinical Interventions, 11(1), Article e70072. https://doi.org/10.1002/trc2.70072

Lips, N., Singh, A., Weir, D., & Karapinar-Carkit, F. (2025). Comparing the performance of multiple trigger tools in identifying medication-related hospital readmissions. Journal of the American Geriatrics Society, 73(1), 162-171. https://doi.org/10.1111/jgs.19216

Bots, S. H., Brown, J., Wong, A. Y. S., Martin, I., Douglas, I., Klungel, O. H., & Schultze, A. (2025). Core Concepts: Self-Controlled Designs in Pharmacoepidemiology. Pharmacoepidemiology and Drug Safety, 34(1), Article e70071. https://doi.org/10.1002/pds.70071

Costa, E., Girotti, S., Mathieu, C., Castellani, C., Ross, J. S., Taylor-Cousar, J. L., & Leufkens, H. G. M. (2025). Differential times of submission and approval of CFTR modulators for the treatment of Cystic Fibrosis in the United States and the European Union. Journal of Cystic Fibrosis, 24(1), 125-132. https://doi.org/10.1016/j.jcf.2024.08.002

Zhou, G., Dael, N., Verweij, S., Balafas, S., Mubarik, S., Rengerink, K. O., Pasmooij, A. M. G., van Baarle, D., Mol, P. G. M., de Bock, G. H., & Hak, E. (2025). Effectiveness of COVID-19 vaccines against SARS-CoV-2 infection and severe outcomes in adults: a systematic review and meta-analysis of European studies published up to 22 January 2024. European Respiratory Review, 34(175), Article 240222. https://doi.org/10.1183/16000617.0222-2024

Dutch CDSS‐efficiency study group, Graafsma, J., van de Garde, E. M. W., Derijks, H. J., Hoge, R. H. L., Klopotowska, J. E., Karapinar-Carkit, F., & van den Bemt, P. M. L. A. (2025). Efficiency of computerized clinical decision support systems involving anticoagulants: A flashmob study in Dutch hospital pharmacies. British Journal of Clinical Pharmacology, 91(1), 157-165. https://doi.org/10.1111/bcp.16236

Costa, E., Ware, R. E., Tshilolo, L., Makani, J., Leufkens, H. G. M., & Luzzatto, L. (2025). Globalization in clinical drug development for sickle cell disease. American Journal of Hematology, 100(1), 4-9. https://doi.org/10.1002/ajh.27525

Jansen, M. S., Dekkers, O. M., Cessie, S. L., Hooft, L., Gardarsdottir, H., de Boer, A., & Groenwold, R. H. H. (2025). Multiple Perspectives on the Need for Real‐World Evidence to Inform Regulatory and Health Technology Assessment Decision‐Making: Scoping Review and Stakeholder Interviews. Pharmacoepidemiology and Drug Safety, 34(1), 1-16. Article e70074. https://doi.org/10.1002/pds.70074

Scholte, M., Grimm, S. E., Pauly, B., Verbeeck, F., Pasmooij, A. M. G., Bouma, B., van Duijn-Wiersma, J., Guney, E., Kesselheim, A. S., Schmidt, H. H. H. W., & Joore, M. A. (2025). Revising EU pharmaceutical legislation: will it foster drug repurposing? Drug Discovery Today, 30(1), Article 104286. https://doi.org/10.1016/j.drudis.2024.104286

Bloem, L. T., Leufkens, H. G. M., Berends, S. E., Vreman, R. A., Hollak, C. E. M., van Weely, S., de Lannoy, L. M., Bertens, P. J. A., & Pasmooij, A. M. G. (2025). Stimulating development of innovative medicines in the European Union: does a new definition for unmet medical need add value? Drug Discovery Today, 30(1), Article 104251. https://doi.org/10.1016/j.drudis.2024.104251

Samukange, W. T., Kluempers, V., Kafere, C., Heinrich, K., Atemnkeng, J., Khadem Broojerdi, A., Tirane, F., Nkansah, E., Maboko, S., Nhukarume, L., Mutoti, K., Gardasdottir, H., Aineplan, N., Mantel-Teeuwisse, A. K., & Reinhardt, J. (2025). Bridging the gap: enhancing blood regulatory functions in African contexts through comparative analysis. Frontiers in Medicine, 12, Article 1519719. https://doi.org/10.3389/fmed.2025.1519719

Møllebæk, M., Gardarsdottir, H., Bikou, A. G., Kodrič, A., Silva, A. M., Andersen, A., Kontogiorgis, C., Poplavska, E., Ahmadizar, F., Dermiki-Gkana, F., Rutkovska, I., Vaz, I. R., Kos, M., Barão, P., Grupstra, R., Alves, T. L., & Almarsdóttir, A. B. (2025). Challenges in the Implementation of EU Risk Minimisation Measures for Medicinal Products in Clinical Practice Guidelines: Mixed Methods Multi-Case Study. Drug Safety, 48(2), 161–177. https://doi.org/10.1007/s40264-024-01487-5

Wolthuis, D. F. G. J., Nijenhuis, M., Soree, B., de Boer-Veger, N. J., Buunk, A. M., Guchelaar, H. J., Risselada, A., Rongen, G. A. P. J. M., van Schaik, R. H. N., Swen, J. J., Touw, D. J., van Westrhenen, R., Deneer, V. H. M., & Houwink, E. J. F. (2025). Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between SLCO1B1 and statins and CYP2C9 and sulfonylureas. European Journal of Human Genetics, 33(4), 413–420. https://doi.org/10.1038/s41431-024-01769-7

Houwaart, R., Wageningen, E. V., & Pieters, T. (2025). Een gezicht geven aan mensen wier verleden vrijwel geheel is uitgewist. Pharmaceutisch Weekblad, 160(18).

Xu, S., Nazar Kermanshahi, S., & Pieters, T. (2025). Gebruik AI altijd als aanvulling op de eigen expertise. Pharmaceutisch Weekblad, 160(18), 14-16.

Rakhorst, W., & Pieters, T. (2025). Grootste Amsterdammer stond aan Wieg (K)NMP. Pharmaceutisch Weekblad, 160(8), 18-19.

Wang, Y. G., Gan, C. P., Beukers-Korver, J., Rosing, H., Li, W. L., Wagenaar, E., Lebre, M. C., Song, J. Y., Pritchard, C., Bin Ali, R., Huijbers, I., Beijnen, J. H., & Schinkel, A. H. (2025). Intestinal human carboxylesterase 2 (CES2) expression rescues drug metabolism and most metabolic syndrome phenotypes in global Ces2 cluster knockout mice. Acta Pharmacologica Sinica, 46(3), 777–793. Article 25747. https://doi.org/10.1038/s41401-024-01407-4

Callenbach, M. H. E., Vreman, R. A., Leopold, C., Mantel-Teeuwisse, A. K., & Goettsch, W. G. (2025). Managed Entry Agreements for High-Cost, One-Off Potentially Curative Therapies: A Framework and Calculation Tool to Determine Their Suitability. PharmacoEconomics, 43(1), 53-66. Article 103433. https://doi.org/10.1007/s40273-024-01433-4

Kaymakci, B., Philbert, D., Hazen, A. C. M., Heringa, M., Kwint, H. F., Zwart, D. L. M., van Dijk, L., Kälvemark Sporrong, S., & Kempen, T. G. H. (2025). Pharmacists’ perspectives on potential pharmacist prescribing: a nationwide survey in the Netherlands. International Journal of Clinical Pharmacy, 47(2), 392–402. Article e2421993. https://doi.org/10.1007/s11096-024-01842-7

Houwen, J. P. A., Lalmohamed, A., Zwaan, J., Egberts, T. C. G., Duyvendak, M., Fiolet, A. T. L., & Mosterd, A. (2025). Response commentary: the effect of colchicine on coagulation in patients with chronic coronary disease who use vitamin K antagonists. European Journal of Clinical Pharmacology. Advance online publication. https://doi.org/10.1007/s00228-025-03917-4

Fliervoet, A., & Pieters, T. (2025). ‘Sla handen ineen in strijd tegen chronisch benzogebruik': Samenwerking apothekers en huisartsen nodig; inbedding in FTO-verband. Pharmaceutisch Weekblad, 160(29-30), 12-13 and 15. https://www.pw.nl/achtergrond/2025/2018sla-handen-ineen-in-strijd-tegen-chronisch-benzogebruik

on behalf of The N-of-1 Task Force of the International Rare Diseases Research Consortium (IRDiRC), Jonker, A. H., Tataru, E. A., Graessner, H., Dimmock, D., Jaffe, A., Baynam, G., Davies, J., Mitkus, S., Iliach, O., Horgan, R., Augustine, E. F., Bateman-House, A., Pasmooij, A. M. G., Yu, T., Synofzik, M., Douville, J., Lapteva, L., Brooks, P. J., ... Aartsma-Rus, A. (2025). The state-of-the-art of N-of-1 therapies and the IRDiRC N-of-1 development roadmap. Nature Reviews Drug Discovery, 24(1), 40-56. Article e10486. https://doi.org/10.1038/s41573-024-01059-3

Trials@Home Consortium, van Rijssel, T. I., van Thiel, G. J. M. W., Gardarsdottir, H., & van Delden, J. J. M. (2025). Which Benefits Can Justify Risks in Research? American Journal of Bioethics, 25(5), 65-75. https://doi.org/10.1080/15265161.2023.2296404

Schmidt, M., Vernooij, R., van Nuland, M., Smeijsters, E., Devriese, L., Mohammad, N. H., Hermens, T., Stammers, J., Swart, C., Egberts, T., Haitjema, S., & Lammers, L. (2024). Impaired liver function: effect on paclitaxel toxicity, dose modifications and overall survival. BMC Cancer, 24(1), Article 1553. https://doi.org/10.1186/s12885-024-13330-2

Hunt, N. B. (2024). Multi-Database Methodologies to Enhance Real-World Evidence Generation. [Doctoral thesis 1 (Research UU / Graduation UU), Universiteit Utrecht]. Utrecht University. https://doi.org/10.33540/2547

Leung, M. W. Y., Bazelier, M. T., Uitdehaag, B. M. J., De Jong, H. J. I., Klungel, O. H., & van de Garde, E. M. W. (2024). Antibiotic Utilization Among People With Multiple Sclerosis in the Netherlands, 2018–2020. Pharmacoepidemiology and Drug Safety, 33(12), Article e70070. https://doi.org/10.1002/pds.70070

Mohmaed Ali, M. I., Nijstad, A. L., Boosman, R. J., Crombag, M. R. B. S., Barnett, S., Veal, G. J., Lalmohamed, A., van Erp, N. P., Steeghs, N., Zwaan, C. M., Beijnen, J. H., Siebinga, H., & Huitema, A. D. R. (2024). A Population Pharmacokinetic Study to Evaluate Doxorubicin Exposure Across All Age Groups. Clinical Pharmacokinetics, 63(12), 1711-1722. https://doi.org/10.1007/s40262-024-01445-5

Falke, C., Karapinar, F., Bouvy, M., Emmelot, M., Belitser, S., Boland, B., O'Mahony, D., Murphy, K. D., Haller, M., Salari, P., Schwenkglenks, M., Rodondi, N., Egberts, T., & Knol, W. (2024). Correction: The association between medication use and health-related quality of life in multimorbid older patients with polypharmacy. European Geriatric Medicine, 15, 1725-1730. https://doi.org/10.1007/s41999-024-01072-0

Iversen, D. B., Dunvald, A.-C. D., Ernst, M. T., Abtahi, S., Souverein, P., Klungel, O., Jeppesen, G. B., Nielsen, F., Brøsen, K., Hammer, H. S., Pötz, O., Damkier, P., Järvinen, E., Pottegård, A., & Stage, T. B. (2024). Dicloxacillin is an inducer of intestinal P-glycoprotein but neither dicloxacillin nor flucloxacillin increases the risk of stroke/systemic embolism in direct oral anticoagulant users. British Journal of Clinical Pharmacology, 90(12), 3252-3262. https://doi.org/10.1111/bcp.16190

Zinken, J. F., Pasmooij, A. M. G., Ederveen, A. G. H., Hoekman, J., & Bloem, L. T. (2024). Environmental risk assessment in the EU regulation of medicines for human use: an analysis of stakeholder perspectives on its current and future role. Drug Discovery Today, 29(12), Article 104213. https://doi.org/10.1016/j.drudis.2024.104213

Brinkhuis, F., Julian, E., van den Ham, H., Ruof, J., & Goettsch, W. (2024). How to Overcome the Remaining Challenges for Successful Implementation of the Eu Hta Regulation: Key Insights From the 2023 European Access Academy Spring Convention and Survey. Value in Health, 27(12).

van Vliet, E., Lipovec, N. Č., van der Goot, M., Abtahi, S., Ribeiro-Vaz, I., Poplavska, E., Dermiki-Gkana, F., Oikonomou, C., Deligianni, E., Kontogiorgis, C., Silva, A. M., Ferreira, P. B. S., Kos, M., Almarsdóttir, A. B., Jacobsen, R., Buhl, C., de Bruijn, A., Hegger, I., & Alves, T. L. (2024). Impact of Regulatory Risk Communication on Thrombosis With Thrombocytopenia Syndrome for COVID-19 Adenovirus Vector Vaccines on European Healthcare Professionals. Pharmacoepidemiology and Drug Safety, 33(12), Article e70057. https://doi.org/10.1002/pds.70057

Callenbach, M., van den Berg, S., Hulsbosch, A., Hollak, C., Leopold, C., Mantel-Teeuwisse, A., & Goettsch, W. (2024). Managed Entry Agreements to Mitigate Uncertainties and Reimbursement Challenges for Orphan Drugs: A Matrix to Determine Their Suitability. Value in Health, 27(12).

Coppes, T., Philbert, D., Van Riet, M., van Gelder, T., Bouvy, M., & Koster, E. (2024). Medication management during risk of dehydration: A qualitative study among elderly patients with impaired renal function and informal caregivers. European Journal of General Practice, 30(1), Article 2413097. https://doi.org/10.1080/13814788.2024.2413097

Luijken, K., Morzywołek, P., van Amsterdam, W., Cinà, G., Hoogland, J., Keogh, R., Krijthe, J. H., Magliacane, S., van Ommen, T., Peek, N., Putter, H., van Smeden, M., Sperrin, M., Wang, J., Weir, D. L., Didelez, V., & van Geloven, N. (2024). Risk-Based Decision Making: Estimands for Sequential Prediction Under Interventions. Biometrical Journal, 66(8), Article e70011. https://doi.org/10.1002/bimj.70011

Taams, A. C., Herberts, C. A., Egberts, A. C. G., Zafiropoulos, N., Pignatti, F., & Bloem, L. T. (2024). Uncertainties about the benefit-risk balance of oncology medicines assessed by the European Medicines Agency. ESMO Open, 9(12), Article 103991. https://doi.org/10.1016/j.esmoop.2024.103991

van Dam, C. J., Kramers, C., Schellekens, A., Bouvy, M., van Dorp, E., Kowal, M. A., Olofsen, E., Dahan, A., Niesters, M., & van Velzen, M. (2024). Cannabis combined with oxycodone for pain relief in fibromyalgia pain: a randomized clinical self-titration trial with focus on adverse events. Frontiers in Pain Research, 5, 1-10. Article 1497111. https://doi.org/10.3389/fpain.2024.1497111

Tamblyn, R., Habib, B., Buckeridge, D. L., Weir, D. L., Frolova, E., Alattar, R., Rogozinsky, J., Beauchamp, C., Pupo, R., Bartlett, S. J., & McDonald, E. (2024). Evaluating the effectiveness of the Smart About Meds (SAM) mobile application among patients discharged from hospital: protocol of a randomised controlled trial. BMJ Open, 14(11), Article e084492. https://doi.org/10.1136/bmjopen-2024-084492

Jiu, L., Wang, J., Versteeg, J.-W., Zhang, Y., Liu, L., Somolinos-Simón, F. J., Tapia-Galisteo, J., García-Sáez, G., Hogervorst, M. A., Li, X., Mantel-Teeuwisse, A. K., & Goettsch, W. G. (2024). Roadmap to Innovation of HTA Methods (IHTAM): insights from three case studies of quantitative methods. International Journal of Technology Assessment in Health Care, 40(1), 1-10. Article e49. https://doi.org/10.1017/S0266462324000564

Elvidge, J., Crabb, N., Delnoij, D., Knies, S., Lundin, D., Houÿez, F., Röning, J., Wang, J., Jiu, L., Bennett, A., Zhang, Y., & Dawoud, D. (2024). Implementing a sandbox approach in health technology assessment: Benefits and recommendations. International Journal of Technology Assessment in Health Care, 40(1), Article e44. https://doi.org/10.1017/S0266462324000412